Mary Schapiro - CVS Health Independent Director
| CVS Stock | EUR 64.57 0.27 0.42% |
Director
Ms. Mary L. Schapiro is Independent Director of the Company. Since January 2014, Ms. Schapiro has served as the Vice Chair of Promontory Advisory Board, part of Promontory Financial Group, a leading strategy, risk management and regulatory compliance firm that was acquired by IBM Corporation in November 2016. She previously served as managing director of Promontory Financial Group from March 2013 through January 2014. From January 2009 through December 2012, Ms. Schapiro was Chairman of the U.S. Securities and Exchange Commission, becoming the first woman to serve as that agencys Chairman. Prior to becoming SEC Chairman, Ms. Schapiro was Chairman and CEO of the Financial Industry Regulatory Authority from 2006 through 2008, and prior to that held a number of key executive positions at FINRA and its predecessor from 1996 through 2006, including Vice Chairman and President of NASD Regulation. She also served as Chairman of the Commodity Futures Trading Commission from 1994 to 1996, and was the only person to serve as Chairman of both the CFTC and the SEC. Ms. Schapiro is also a director of The London Stock Exchange Group plc, which engages in market infrastructure and the capital markets business since 2017.
| Age | 62 |
| Tenure | 7 years |
| Phone | 401-765-1500 |
| Web | https://www.cvshealth.com |
CVS Health Management Efficiency
The company has return on total asset (ROA) of 0.0418 % which means that it generated a profit of $0.0418 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0568 %, meaning that it generated $0.0568 on every $100 dollars invested by stockholders. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | DIRECTOR Age | ||
| William Louden | ONLINE BLOCKCHPLC LS 05 | N/A | |
| Jonathan Mullins | ONLINE BLOCKCHPLC LS 05 | 42 | |
| Clement Chambers | ONLINE BLOCKCHPLC LS 05 | 51 | |
| David Wiadrowski | CARSALESCOM | N/A | |
| Walter Pisciotta | CARSALESCOM | 69 | |
| David OReilly | British American Tobacco | 57 | |
| Kee Wong | CARSALESCOM | N/A | |
| Paul Lageweg | British American Tobacco | 53 | |
| Tadeu Marroco | British American Tobacco | 57 | |
| Edwina Gilbert | CARSALESCOM | N/A | |
Management Performance
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 |
CVS Health Corp Leadership Team
Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Ludwig, Independent Director | ||
| J Joyner, Executive Vice President | ||
| David Dorman, Independent Chairman of the Board | ||
| Shawn Guertin, Ex CFO | ||
| Richard Bracken, Independent Director | ||
| Mary Schapiro, Independent Director | ||
| Richard Swift, Independent Director | ||
| Fernando Aguirre, Independent Director | ||
| Norman Greve, Chief Officer | ||
| Laurie Havanec, Ex Officer | ||
| NancyAnn DeParle, Independent Director | ||
| Tilak Mandadi, Digital Data | ||
| David Brown, Independent Director | ||
| JeanPierre Millon, Independent Director | ||
| Mark Bertolini, Independent Director | ||
| Alecia DeCoudreaux, Independent Director | ||
| William Weldon, Independent Director | ||
| Kevin Hourican, President of CVS Pharmacy | ||
| Larry McGrath, Sr Relations | ||
| Stephen Gold, Senior Vice President CIO | ||
| Troyen Brennan, Executive Vice President Chief Medical Officer | ||
| Lisa Bisaccia, Chief Human Resource Officer, Senior Vice President | ||
| David Denton, CFO, Executive Vice President | ||
| Karen Lynch, CEO Pres | ||
| Helena Foulkes, Executive Vice President and Presidentident of CVS/pharmacy | ||
| Thomas Moriarty, Executive Vice President General Counsel | ||
| Tony White, Independent Director | ||
| Anne Finucane, Independent Director | ||
| Derica Rice, President - CVS Caremark | ||
| James Clark, Senior Vice President Chief Accounting Officer, Controller | ||
| Per Lofberg, Executive Vice President | ||
| Eva Boratto, Senior Vice President Chief Accounting Officer, Controller | ||
| David Joyner, Executive Vice President | ||
| David Falkowski, Ex Officer | ||
| Jonathan Roberts, Executive Vice President; President of CVS Caremark Pharmacy Services | ||
| Larry Merlo, President CEO, Director | ||
| Alan MD, Ex Services | ||
| Roger Farah, Independent Director | ||
| Andrew Sussman, Senior Vice President Associate Chief Medical Officer | ||
| Robert Kraft, Executive Vice President |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 173.98 B | |||
| Shares Outstanding | 1.28 B | |||
| Shares Owned By Insiders | 0.41 % | |||
| Shares Owned By Institutions | 82.27 % | |||
| Price To Earning | 14.93 X | |||
| Price To Book | 1.85 X |
Pair Trading with CVS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.Moving together with CVS Stock
| 0.68 | MHG | Molina Healthcare | PairCorr |
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for CVS Stock analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world |